<DOC>
	<DOCNO>NCT02619734</DOCNO>
	<brief_summary>The purpose study evaluate safety efficacy autologous bone marrow stem cell implantation treatment leg ulcer adult patient sickle cell disease .</brief_summary>
	<brief_title>Autologous Bone Marrow Stem Cells Chronic Leg Ulcer Treatment Sickle Cell Disease</brief_title>
	<detailed_description>Implantation bone marrow mononuclear cell , include endothelial progenitor cell mesenchymal stromal cell , leg ulcer show improve wound healing . In present study safety efficacy autologous bone marrow mononuclear cell implantation investigate patient chronic leg ulcer . Forty case enrol . Improvement pain , rate extent leg ulcer wound heal measure change wound surface area evaluate one year .</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Anemia , Sickle Cell</mesh_term>
	<mesh_term>Leg Ulcer</mesh_term>
	<mesh_term>Skin Ulcer</mesh_term>
	<criteria>Stable sickle cell disease patient Patient hospitalize dermatology unit Patient evolutive leg ulcer since 1 year No infection time surgery Patient competent give inform consent Patients history corticosteroid active therapy infection limb affect ulcer Recurrent painful crisis , Immunosuppressive drug therapy , Pregnancy , Presence neoplastic disease clinical concurrent condition sickle cell disease predispose development leg ulcer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>Cell Therapy</keyword>
	<keyword>Sickle cell disease</keyword>
	<keyword>Autologous implantation</keyword>
	<keyword>Mesenchymal stromal cell</keyword>
	<keyword>Edothelial Progenitor cell</keyword>
</DOC>